to the Golgi is mediated by the sequential action of two coat complexes: COPII concentrates cargo for secretion at ER export sites, then COPI is subsequently recruited to nascent carriers and retrieves recycling proteins back to the ER. These carriers then move towards the Golgi along microtubules, driven by the dynein/dynactin complexes. Here we show that the Sec23p component of the COPII complex directly interacts with the dynactin complex through the carboxy-terminal cargobinding domain of p150
the ER and subsequent VTC motility. ERES align along microtubules in certain cell types 8 , Golgi-directed VTCs localize along a population of stable microtubules 9, 10 and translocate along microtubules towards the Golgi in a dynactin-dependent manner 6 , and the plus-end-directed motor protein kinesin has been shown to localize to ERES in vitro 11 and to pre-Golgi intermediates (VTCs) in vivo 12 . However, little is known about the mechanisms that couple membranes of the early secretory pathway to microtubules. How is the localization of COPII to discrete sites generated and maintained? How are VTCs linked to microtubules, and how is motility of VTCs regulated?
ERES undergo predominantly short-but also long-range movements in mammalian cells that are completely inhibited following depolymerization of microtubules 13, 14 . Imaging of live cells labelled with yellow fluorescent protein (YFP)-Sec23Ap 15 and rhodamine-tubulin showed that the majority of ERES localized in the vicinity of microtubules (Fig. 1a) . Time-lapse analysis showed that dynamic microtubules frequently repolymerized along trajectories that passed one or more ERES ( Fig. 1a and see Supplementary Information, Movie 1, enlarged in Fig. 1b) . The association of ERES with microtubules persisted for at least several minutes ( Fig. 1a and see Supplementary Information, Movie 1, enlarged in Fig. 1b ). These data suggest that a significant fraction of growing microtubules are targeted towards ERES and are consistent with a 'search-and-capture' mechanism for the targeting of growing microtubules to endomembranes 16 . To obtain more direct evidence for this we tested the targeting of growing microtubules using green fluorescent protein (GFP)-labelled plus-end tracking proteins (+TIPs) 17 . Figure 1c (and see Supplementary Information, Movies 2 and 3) shows that GFPp150
Glued (ref. 16 ) labels the plus ends of microtubules in HeLa cells (Fig. 1c, arrow) and that these structures migrate towards and through ERES labelled with GFP-Sec23Ap (Fig. 1c , arrowhead, and see Fig. 1d ). We obtained identical data using an alternative +TIP-GFP-end-binding protein 1 (GFP-EB1) 18 (data not shown). To extend these observations, we measured the association of newly polymerized microtubules with ERES following incubation with and subsequent washout of nocodazole. Consistent with the data presented in Fig. 1 , newly polymerizing microtubules become rapidly associated with ERES after nocodazole washout (Fig. 2a) . Newly polymerized microtubules associated more frequently with COPII when compared with either γ-adaptin-positive structures or peroxisomes (data not shown). Analyses of fixed and immunostained cells confirmed these observations with endogenous proteins (data not shown). Injection of anti-EAGE (a function blocking antibody directed against the COPI complex 19 ), or of Sar1p (H79G) (a dominant negative mutant that inhibits COPII 5 ), reduced the number of microtubules that had at least one associated ERES, compared with controls ( Fig. 2a, b) . Inactivation of COPII and COPI function also reduced the number of ERES associated with at least one microtubule (Fig. 2a, c) . These data imply that a functional early secretory pathway is required for the association of ERES with microtubules.
These data support the hypothesis that association of membranes and microtubules is initiated at an early, COPII-dependent stage of ER-to-Golgi transport. We therefore set out to identify COPII-interacting molecules as potential mediators of the association of ERES with microtubules. Two-hybrid screening with Sec23Ap identified one positive clone encoding a C-terminal fragment of p150
Glued (amino acids 938-1254, consequently named CT Glued ). p150 Glued is a component of the dynactin complex that interacts with the dynein motor 20 and also binds microtubules 21 . This clone was found to specifically interact with Sec23Ap but not lamin (Fig. 3a) . Further assays showed that CT Glued also interacts with Sec24Dp but not with Sec13p or Sec31Ap (Fig. 3a) .
A direct interaction between Sec23Ap and p150
Glued was demonstrated using surface plasmon resonance (SPR) and 'glutathione S-transferase (GST) pull-down' experiments. Figure 3b shows that an interaction was detectable with GST-CT Glued (black trace) but not with GST alone (grey). Figure 3c shows the averaged binding of His 6 -hSec23Ap to GST-CT Glued compared with GST from six representative SPR experiments of which one is shown in Fig. 3b . Binding of His 6 -hSec23Ap to GST-CT Glued is only very weakly detectable with binding profiles indicative of a very fast off-rate. We were also able to demonstrate binding of His 6 -Sec23Ap to immobilized GST-CT Glued (Fig. 3d , lane 2) confirming that this interaction is direct. Sec23Ap interacted with p150
Glued by co-immunoprecipitation from HeLa cell lysates (Fig. 3e) . Antibodies specific for Sar1p could also immunoprecipitate p150
Glued (Fig. 3f) . This was less efficient than immunoprecipitation of p150
Glued with anti-Sec23Ap antibodies, probably owing to the transient nature of COPII complex assembly 22 (and see Supplementary Information, Table 1 ). The interaction is specific to Sec23Ap because we were unable to co-immunoprecipitate p150 Glued with antibodies specific to either Sec31Ap 23 or β′-COP 24 (of the COPI complex) (Fig. 3f) . The lower panels of Fig. 3f show that the antibodies used for immunoprecipitation are effective in immunoprecipitation of their targets. Furthermore, we found that overexpression of a cyan Glued and GFP-Sec23Ap were imaged at 37
°C . GFP-p150 Glued predominantly labels the growing tips of microtubules (arrows), which can be seen to track through the cytoplasm directly through GFP-Sec23Ap-labelled ERES (arrowheads); see Supplementary Glued that could be immunoprecipitated with anti-Sec23Ap but not by anti-p50 dynamitin (Fig. 3g ). Immunofluorescence staining of fixed cells revealed limited but definite colocalization of COPII and p150
Glued (Fig. 4a, b) . Eight per cent (± 1.7%) of COPII structures within any one cell colocalized with p150
Glued (>1,000 Sec23Ap-labelled structures analysed). In contrast, only 2.9% (± 0.28%) of γ-adaptin-positive structures (clearly defined puncta in the periphery of cells) colocalized with p150
Glued (>800 γ-adaptin-positive structures analysed). A similar degree of colocalization was seen with two different anti-p150
Glued monoclonal antibodies (Fig. 4a, b) and one polyclonal 16 (data not shown). This of course reflects the distribution of these proteins at the instant at which the cells were fixed. In addition to the predominant localization of p150
Glued to plus ends, there will also be a soluble pool in these cells, but this is largely extracted by methanol fixation. We do not detect significant punctate labelling of p150
Glued throughout the cell, other than at microtubule plus ends. We have observed a similar association of structures that label with antibodies directed against dynein heavy chain 1a, at or adjacent to COPII-labelled structures (data not shown). Intriguingly, on depolymerization of microtubules with nocodazole for 10 or 30 min (depolymerization of microtubules being confirmed by immunofluorescence with anti-α-tubulin antibodies (data not shown)) a population of p150 Glued localized in the direct vicinity of ERES (Fig. 4c, d, arrowheads in d) . This may represent binding of dynactin to newly formed VTCs and, in these experiments, we cannot discriminate between direct recruitment to VTCs and COPII-dependent recruitment.
The data presented above suggest the presence of a protein interaction network that functions to coordinate vesicle generation with subsequent VTC formation and transport. We therefore measured the rate of turnover of COPII components on the ER membrane using fluorescence recovery after photobleaching (FRAP; see Supplementary Information, Methods and Fig. S1 ). Overexpression of either p150
Glued or CFP-CT Glued caused similar changes to the rate of recycling of both Sec23Ap (t ½ decreased from 4.0 ± 0.3 s to 1.6 ± 0.4 s in cells expressing CT Glued ) and Sec31Ap (t ½ decreased from 3.1 ± 0.1 s to 1.5 ± 0.3 s) compared with control cells (see Supplementary Information, Table 1 ). Similar data were obtained with Sec24Dp and Sec13p (data not shown). Microinjection of p50 dynamitin also substantially accelerated the turnover of these COPII components. Depolymerization of microtubules had little effect on the steady state distribution of COPII 14 (Fig. 4) . However, turnover at single ERES of both Sec23Ap and Sec31Ap was significantly accelerated following depolymerization of microtubules with nocodazole (t ½ decreased from 4.0 ± 0.3 s to 2.6 ± 0.2 s for Sec23Ap and from 3.1 ± 0.1 s to 1.9 ± 0.4 s for Sec31Ap, see Supplementary Information, Table 1 ).
Disruption of COPII function would be expected to have an effect on cargo export from the ER. We therefore examined the effects of expression of CFP-CT Glued on export from the ER of the widely used secretory cargo ts045-G from the ER by time-lapse microscopy 4, 6, 14 . a substantial fraction of the expressed ts045-G-GFP reaches the Golgi within 5 min (300 s, arrowheads). In contrast, it is not until 15 min (900 s, arrowhead) that a similar quantity of ts045-G-GFP in the Golgi of cells expressing CFP-CT Glued can be seen. Indeed in the earlier frames from this sequence (0-600 s, see Supplementary Information, Movies 4 and 5), it becomes clear that there is a defect in the formation of punctate, ts045-G-GFP-containing transport carriers (Fig. 5b) . In CFP-transfected cells, Glued . (a) Two-hybrid screening reveals a specific interaction between Sec23Ap and the C terminus of p150
Glued (amino acids 938-1254). All colonies grow on double dropout medium (DDO) but only those showing a positive interaction grow on quadruple dropout (QDO). p150
Glued (amino acids 938-1254) interacts specifically with Sec23Ap and Sec24Dp but not with lamin, Sec13p or Sec31Ap. (b) Surface plasmon resonance demonstrates a direct interaction between Sec23Ap and p150
Glued . One hundred resonance units (RUs) of either GST or GST-CT Glued were immobilized. His 6 -hSec23Ap shows no binding to GST (grey) but binds GST-CT Glued (black). Note the large increase in RUs immediately following injection of His 6 -hSec23Ap (t = 0 s) is due to slight differences in refractive indices of the buffers; RUs increase as His 6 -hSec23Ap flows across the surface loaded with GST-CT Glued but not that loaded with GST. At t = 60 s His 6 -hSec23Ap is exchanged for PBS. Fast dissociation of His 6 -hSec23Ap (t = 60 s) is followed by slow dissociation of a more tightly bound component (60-120 s). Glued that can be co-immunoprecipitated with Sec23Ap (left-hand panels) but does not affect co-immunoprecipitation of p150 ts045-G to the plasma membrane shows that CFP-CT Glued significantly inhibits transport to the plasma membrane (Fig. 5c ). These data show that the delay in transport is perpetuated through the secretory pathway.
It is possible that these defects result from direct disruption of the dynactin complex. However, these data are different from those seen on expression of p50 dynamitin (ref. 6). Critically, p50 dynamitin results in an accumulation of cargo in punctate structures (ERES and VTCs) 6 , but CT Glued inhibits any such accumulation at ERES, and cargo export from the ER is delayed (Fig. 5) . The velocities of VTCs identified in these time-lapse movies were measured using particle tracking. Average velocities of VTCs were 1.21 ± 0.34 µm s −1 in CFP-transfected cells and 1.24 ± 0.30 µm s −1 in CFP-CT Glued -transfected cells. Figure 5d shows a histogram of the average velocity of these VTCs along with the scatter of individual measurements. We conclude from this that there is no difference in VTC velocity in these two experiments. It is possible that overexpression of CFP-CT Glued mimics the effects of p50 dynamitin and inhibits traffic through functional disruption of dynactin structure (that is, uncoupling of the side arm from the central domain of dynactin 25, 26 ). Sedimentation analyses reveal that this is not the case (see Supplementary Information, Fig. S2 ). These data show that expression of CFP-CT Glued acts by a mechanism distinct to that of p50 dynamitin , most probably through inhibition of the Sec23Ap-p150 Glued interaction (see also Fig. 3g) . Furthermore, overexpression of dynactin components, such as p50 dynamitin , causes a variety of defects including disorganization of microtubules and Golgi fragmentation 27 . Expression of CT Glued did not cause these effects (see Supplementary Information,  Fig. S3 ), consistent with a defect in one or more aspects of ER-to-Golgi transport, but not with gross defects in Golgi organization.
The experiments described here suggest that the association of ERES with microtubules is mediated directly or indirectly by the dynactin complex. We have shown that ERES rapidly associate with newly polymerized microtubules, the tips of which carry p150 Glued 28 . One could envisage that these newly polymerizing microtubules grow in close enough proximity to ERES for this to act as a mechanism of targeted delivery of p150 Glued to ERES, or indeed in capture of microtubules by ERES, which already have p150
Glued . The interaction of COPII with dynactin is consistent with previous findings 16 showing a role for the regulated binding of dynactin to newly formed transport carriers emerging from the ER. It is conceivable that a pool of dynactin localizes to ERES when it is associated along the length, rather than with the tips of microtubules. Our data suggest that an intact microtubule cytoskeleton is not required for recruitment of p150
Glued to ERES, thus dynactin may be recruited to ERES from cytosol. Not enough is known about the dynamics of p150
Glued at plus ends, or indeed along the rest of the microtubule length, to define this further. The number of COPII-dynactin 'capture' events happening at an ERES (which in a typical ∼1 µm area of membrane is potentially high) means that the association of these sites with microtubules is maintained.
We have shown that p150 Glued can interact, albeit weakly, with partially assembled COPII (the pre-budding complex of Sar1p and Sec23p). We cannot detect an interaction between Sec31p and p150
Glued , but we cannot conclusively define whether this is owing to the rapid dissociation of assembled COPII 22 , an inability of our antibodies to detect an association, or because p150
Glued does not associate with fully assembled COPII. The association of dynactin with COPII is transitory in nature as dynactin is then 'transferred' to the nascent VTC where it is probably anchored by another dynactin receptor such as spectrin, which is known to anchor dynactin on Golgi membranes 29 . Because VTCs are coated with COPI 30 en route to the Golgi but not with COPII 13, 14 , there are likely to be alternative binding partners for p150 Glued , or other components of the dynactin or dynein complexes, to mediate subsequent transport. Monitoring the turnover of COPII components at ERES suggests that an intact dynactin complex serves to stabilize the COPII coat on the membrane. Stable association of COPII with membranes and functional coupling to microtubules is likely to be a precursor to productive budding events in living cells. We show that p50 dynamitin expression disrupts the dynactin complex and should thus interfere with both p50 dynamitin and p150 Glued function; in contrast, CT Glued expression does not seem to disrupt the dynactin complex and should not directly interfere with p50 dynamitin function. On the basis of these results we conclude that the changes in COPII dynamics seen with CT Glued expression are due to the inhibited interaction of p150
Glued with Sec23p. Thus, expression of CT Glued inhibits export of cargo from the ER, but not the motility of VTCs once they have formed, consistent with a role for dynactin at an early stage of COPII function.
Most ERES themselves are relatively immobile 13, 14 and, despite rapid recycling of COPII components on and off the ER membrane, are in fact very stable structures 14 . The interaction of COPII with dynactin therefore supports a role for COPII in the generation of membrane domains to which machinery such as dynactin, dynein, Rabs 31 , tethers 31 and SNAREs 32, 33 can be recruited in advance of their requirement. This would increase the efficiency of a complex process, including vesicle formation, microtubule membrane interactions and activity of motors, that needs to be tightly regulated in space and time. In conclusion, we have identified a direct link between the ER export machinery and the microtubule cytoskeleton. These data provide a molecular mechanism linking cargo export from ER exit sites to microtubules for dynein-dependent, directional transport to the Golgi.
METHODS

Materials.
Nocodazole was from Merck Biosciences (Nottingham, UK); plasmids encoding YFP-Sec23Ap and CFP-Sec24Dp (where A and D denote the isoforms of these proteins) are described in ref. 15 ; Sec31Ap was a gift from F. Gorelick (Yale, USA) and was transferred from pCR2.1 vectors into pECFP-C1 and pEYFP-C1 vectors (Clontech, Palo Alto, CA) using flanking EcoR1 sites. cDNA encoding YFP-PMP4, a peroxisomal marker, was a gift from J. Simpson (EMBL, Heidelberg, Germany); cDNA encoding p50 dynamitin (ref. 25) , recombinant p50 dynamitin and rhodamine-tubulin were gifts from I. Vernos (EMBL, Heidelberg); chick p150
Glued and p50 dynamitin were gifts from T. Schroer (Johns Hopkins, Baltimore, MD); polyclonal anti-Sec31p was a gift from W. Hong (IMCB, Singapore); anti-VG and YFP-ts-045-G were from K. Simons (MPI-CBG, Dresden, Germany); monoclonal anti-α-tubulin (DM1A) was from Neomarkers (Fremont, CA); EAGE is described in ref. 21 ; anti-Sec23Ap was from Affinity Bioreagents (Golden, CO); anti-DHC1a was provided by V. Allan (University of Manchester, UK); and anti-BSTR has been described previously 24 . Monoclonal antibodies directed against p50 dynamitin (611003) and p150 ) was microinjected and expressed for 16 h. Rhodamine-tubulin was diluted to 5 µg ml −1 in ice-cold injection buffer (5 mM sodium phosphate, 100 mM KCl, pH 7.3), centrifuged at 4 °C and subsequently injected into expressing cells. Cells were left to incubate for several hours before imaging to ensure incorporation into microtubules. Recombinant p50 dynamitin (5 mg ml dynamitin and CFP-CT Glued were co-injected with a plasmid expressing YFP-Sec23Ap, and left to express for 16 h.
Microtubule repolymerization and quantification of colocalization. Vero cells were microinjected with constructs encoding YFP-Sec23Ap for 16-18 h, and microinjected with 1 mg ml −1 rabbit IgG or 1 mg ml −1 EAGE, each with a co-injection marker of 0.03 mg ml −1 rhodamine-dextran. Sar1p (H79G) inhibition was achieved by co-expression from a plasmid. Cells were then treated with 10 µM nocodazole for 1 h at 37 °C. Nocodazole was then washed out using pre-warmed medium. Cells were then incubated at 37ºC for 3 min, fixed, and stained for endogenous α-tubulin. Images of stained cells were acquired with a Zeiss (Thornwood, NY) microscope system equipped with a cooled CCD (charge-coupled device) camera (Cell Observer). The tubulin and COPII images were separated and individual randomly selected centrosomal microtubules were highlighted with an overlay that was superimposed onto the COPII image using IPLab software package (Scanalytics, Fairfax, VA). Association of microtubules with ERES was defined as being observed when the microtubule overlay was in contact with COPII-labelled ERES. COPII-coated ERES in close vicinity to microtubules were not counted as associated (see Fig. 2a, c for examples) . The percentage of the microtubules associated with at least one ERES and the percentage of ERES associated with at least one microtubule (Fig. 2) was determined and the data normalized to the values obtained in unperturbed control cells (set as 100%). In all experiments, at least 10 cells were measured for each condition. Identical results were obtained in living cells expressing YFP-α-tubulin and YFP-Sec23Ap (data not shown).
Live cell imaging of microtubules and COPII. Vero cells were treated as above. Cells were either untreated or subjected to the repolymerization assay described above. Immediately after washout of nocodazole, cells were imaged in pre-warmed carbonate free imaging medium, at 37 °C, using an Ultraview RS imaging system (Perkin Elmer, Wellesley, MA), fitted with argon (488 nm) and argon/krypton (568 nm) ion lasers, with ×100 1.3 N.A. oil immersion objective (Carl Zeiss, Jena, Germany). Images were acquired continuously, with intervals between frames of 0.8 s. Channels were acquired sequentially, using 50% laser power.
Immunofluorescence and microscopy. Living cells were imaged as previously described 14 . For immunofluorescence, cells were fixed with methanol at −20 ο C for 4 min and processed as described 14 . HeLa, Vero or PtK2 cells were imaged using an Olympus/TILL Photonics imaging system as described 15 , Leica TCS-NT upright confocal microscope or Leica TCS-SP2 AOBS confocal microscope. Images were processed using Photoshop 6.0 (Adobe, Uxbridge, UK), ImageJ (http://rsb.info. nih.giv.ij) and QuickTime Pro (Apple, Cupertino, CA). Montages were generated using Adobe Illustrator 10 (Adobe). Movies were compiled in QuickTime Pro using 'Photo JPEG' compression. 
Two-hybrid library screening.
A human adult brain two-hybrid library (Clontech, Oxford, UK) was screened using human Sec23Ap as bait by yeast mating using the Matchmaker III system. Independent clones (2 × 10 6 ) were screened, positive clones isolated and interaction confirmed by retransformation and analysis using negative control constructs as described in the text. Putative positives were identified by DNA sequencing. Positive interactions were confirmed using both α-gal and β-gal colorimetric assays.
Immunoprecipitation. HeLa cells were grown to 90% confluence, lysed in RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, protease inhibitor cocktail (Calbiochem, Nottingham, UK)) and subjected to immunoprecipitation with primary antibodies, followed by incubation with GammaBind-G sepharose (Amersham Biosciences, Chalfont St Giles, UK). Complexes were washed three times for 5 min each in RIPA followed by SDS-PAGE and immunoblotting. Proteins were separated using 3-8% Tris-acetate or 4-12% Bis-Tris gels (Invitrogen, Carlsbad, CA) and transferred to PVDF membranes. Blots were developed using chemiluminescent detection (Roche, Lewes, UK). For the experiments shown in Fig. 3f , cells were lysed in 50 mM Tris-HCl pH 7.4, 100 mM NaCl, 1% Triton X-100 with protease inhibitor cocktail; blots in Fig. 3f were developed using SuperSignal West Femto chemiluminescent substrate (Pierce/Perbio, Cramlington, UK).
Protein expression and purification. The two-hybrid clone corresponding to the C terminus of p150
Glued was cloned into pGEX4T2 (Amersham Pharmacia Biotech, Cardiff, UK). GST-CT Glued and GST were expressed and purified according to the manufacturer's standard protocols. The coding region of human Sec23Ap was cloned into pFastBac-HTa (Invitrogen). Recombinant bacmids were generated and transfected into Sf9 cells. Viruses were collected, amplified and used for expression in Sf9 cells. Cells were lysed in lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, complete protease inhibitors (Roche, Lewes, UK)) and purified using Talon metal affinity chromatography (Clontech) according to manufacturers' protocols.
Direct binding assays.
Binding analysis was performed using bacterially expressed GST and GST-CT Glued was purified using glutathione-sepharose (Amersham Biosciences, Little Chalfont, UK) according to the manufacturer's instructions. His 6 -Sec23Ap was purified from baculovirus-infected HighFive (Invitrogen) cells using Talon affinity resin (Clontech). Protein was eluted with 100 mM EDTA and used directly in the binding assay. Binding was measured by surface plasmon resonance using a Biacore 1000 system (Biacore, Uppsala, Sweden) at a flow rate of 10 µl min −1 and using phosphate-buffered saline as running buffer. An antibody to GST (Amersham Pharmacia Biotech, Piscataway, NJ) was immobilized on a CM5 dextran sensor chip (Biacore, Neuchâtel, Switzerland) using amine-coupling chemistry. Equal quantities (100 resonance units, RU) of GST or GST-CT Glued were captured using anti-GST antibodies followed by measurement of interaction with His 6 -hSec23Ap over 60 s. In control experiments, His 6 -hSec23Ap did not show any binding to the dextran matrix directly or to the anti-GST antibody (data not shown). 'GST pull-down' experiments were performed by incubating 5 µg His 6 -Sec23Ap with 5 µg of GST or GST-CT Glued immobilized on glutathione sepharose for 2 h at 4 ο C. Beads were then washed three times for 5 min each in PBS followed by boiling in SDS sample buffer, and SDS-PAGE and immunoblotting using an anti-Sec23Ap antibody. Sedimentation assay. Integrity of the dynactin complex was analysed by sucrose density sedimentation. The protocol was based on that of ref. 25 . Cells grown in 100-mm dishes were incubated in 1 ml of sedimentation buffer (50 mM TrisHCl pH 7.5, 150 mM NaCl, 1 mM EDTA, Complete Protease inhibitor cocktail) containing 1% NP-40 for 15 min at 4 °C. Cell lysates were centrifuged at 25,000g (Eppendorf 5417R) at 4 °C for 30 min and the supernatant was recovered. Sucrose gradients (10 ml of 5-20% sucrose in sedimentation buffer) were prepared and 800 µl of each extract were carefully layered on top. The gradients were centrifuged in a TH-641 swing out rotor (Sorvall OTD65B Ultracentrifuge) at 96,330g for 18 h at 4 °C. 1-ml fractions were collected and 20 µl analysed by SDS-PAGE followed by western blotting with antibodies directed against p50 dynamitin or p150 
